Cargando…
Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
Restricted drug entry to the brain that is closely associated with the existence of the blood brain barrier (BBB) has limited the accessibility of most potential active therapeutic compounds to the brain from the systemic circulation. Recently, evidences for the presence of direct nose-to-brain drug...
Autores principales: | Hong, Soon-Seok, Oh, Kyung Taek, Choi, Han-Gon, Lim, Soo-Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835450/ https://www.ncbi.nlm.nih.gov/pubmed/31627301 http://dx.doi.org/10.3390/pharmaceutics11100540 |
Ejemplares similares
-
Effects of PEG-Linker Chain Length of Folate-Linked Liposomal Formulations on Targeting Ability and Antitumor Activity of Encapsulated Drug
por: Lim, Chaemin, et al.
Publicado: (2023) -
Formulation‐based approaches for dermal delivery of vaccines and therapeutic nucleic acids: Recent advances and future perspectives
por: Sallam, Marwa A., et al.
Publicado: (2021) -
Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery
por: T. de Barros, Cecilia, et al.
Publicado: (2020) -
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery
por: Bajracharya, Rajiv, et al.
Publicado: (2019) -
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
por: Zhao, Zhongwei, et al.
Publicado: (2019)